Please assess the completion status of the following clinical trial:

Trial Title: Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 40 and 89 years old~* Diagnosis of treated POAG (including normal tension glaucoma (NTG))~* All IOP measurements during the VF period (to be described further) equal or lower than 18 mmHg and/or on average equal or lower than 16 mmHg in the same period~* Documented glaucomatous VF damage at baseline, characterized by glaucoma hemifield test result outside normal limits on at least 2 consecutive VF tests or the presence of at least 3 contiguous test points within the same hemifield on the pattern deviation plot at p\<0.01, with at least 1 point at p \< 0.005~* At least 8 visual field tests carried out within at least 2 years, all with fixation losses and false positive/negative results equal or less than 33%~* For fast progressing eyes, 1) pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p\<0.01 or 2) a global rate of VF change based on mean deviation (MD) more negative than -1.0 dB/year~* For slowly or minimally progressing eyes a VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression as described above~* Not more than 6 diopters spherical equivalent on the study eye~* Have given written informed consent, prior to any investigational procedures~Exclusion Criteria:~* Baseline VF MD more negative than -15 dB. The rationale here is that in severely damaged visual fields, one may not be able to detect and measure rates of progression due to a 'floor effect'~* Corneal or conjunctival abnormality precluding contact lens adaptation~* Severe dry eye syndrome or other ocular disease~* Patients with angle closure glaucoma, traumatic glaucoma or uveitic glaucoma~* Patients with previous intraocular surgery in the enrolled eye, including cataract surgery~* Patients with allergy to corneal anesthetic~* Patients with contraindications for silicone contact lens wear~* Patients not able to understand the character and individual consequences of the investigation~* Participation in unrelated clinical research within the last 4 weeks

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- SENSIMED Triggerfish® (Type: EXPERIMENTAL): Device: portable device that monitors the 24-hour IOP pattern by a wireless contact lens sensor placed on the eye that sends its signals via an antenna around the orbital cavity to a recorder. Upon completion, the recording can be transmitted to a computer for read-out and visualization.

Based on this trial design, predict the completion outcome and termination type (if applicable).